cV5 Diagnostic Ultrasound System vs LINQ II Insertable Cardiac Monitor

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by Samsung Medison
VS

AI Verdict

These tools are adjacent in the healthcare AI landscape, both leveraging AI in cardiology but for distinct purposes. The Samsung cV5 is a diagnostic ultrasound system focused on real-time imaging and workflow efficiency across multiple specialties, while the Medtronic LINQ II is an insertable cardiac monitor designed for long-term, continuous heart rhythm monitoring and arrhythmia diagnosis. Clinicians would choose the cV5 for immediate diagnostic imaging needs and the LINQ II for ongoing, passive cardiac rhythm surveillance.

Choose cV5 Diagnostic Ultrasound System if…

Choose the Samsung cV5 Diagnostic Ultrasound System if your practice requires a versatile, high-resolution imaging solution for real-time diagnostic assessment across multiple specialties like cardiology, obstetrics/gynecology, and radiology. This system is ideal for clinics needing AI-assisted tools for enhanced image quality and streamlined workflows in diverse diagnostic scenarios, from fetal biometry to cardiac function analysis.

View cV5 Diagnostic Ultrasound System →

Choose LINQ II Insertable Cardiac Monitor if…

Choose the Medtronic LINQ II Insertable Cardiac Monitor if you need a long-term, discreet solution for continuous heart rhythm monitoring to diagnose infrequent or paroxysmal arrhythmias. This device is best suited for patients requiring extended monitoring (up to 4.5 years) with AI-powered accuracy and remote management capabilities, offering a less intrusive alternative to external monitors for elusive cardiac events.

View LINQ II Insertable Cardiac Monitor →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature cV5 Diagnostic Ultrasound System LINQ II Insertable Cardiac Monitor
Deployment On-premise (ultrasound system) Subcutaneous implant with remote monitoring via mobile app or home communicator.
FDA Status Cleared AI-estimated Cleared AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

cV5 Diagnostic Ultrasound System

Tool A emphasizes streamlined workflows, ergonomic design, and a large tilting touchscreen, directly enhancing the hands-on experience for clinicians during diagnostic procedures. Its suite of AI productivity tools like EzExam+u2122 and QuickScanu2122 further simplifies complex tasks and improves operational efficiency for the user.

Clinical Value

LINQ II Insertable Cardiac Monitor

Tool B provides long-term, continuous heart rhythm monitoring for up to 4.5 years, leveraging AccuRhythmu2122 AI algorithms for enhanced accuracy in diagnosing arrhythmias, including an innovative PVC detection algorithm. This sustained, precise monitoring for critical cardiac conditions offers a distinct and profound clinical benefit that a single diagnostic scan cannot replicate.

Pricing & Value

Tie

Both tools lack transparent, publicly disclosed pricing information, requiring direct contact with the vendor for details. Neither offers a free trial, making it impossible to conduct a head-to-head comparison of their cost-effectiveness or overall value without specific financial data.

Enterprise Readiness

LINQ II Insertable Cardiac Monitor

Tool B explicitly targets a wide range from 'Solo to large health systems' and boasts over 1 million patients served worldwide, demonstrating a proven track record and infrastructure for large-scale adoption. Its hybrid deployment model and Medtronic's long history as a global medical device leader further underscore its robust enterprise readiness.

Innovation

cV5 Diagnostic Ultrasound System

Tool A showcases extensive innovation through its 'Crystal Architectureu2122' for enhanced image quality and a broad array of AI & Productivity Tools such as HeartAssistu2122, AutoEF, and ArterialAnalysisu2122 for diverse diagnostic applications. This wide integration of AI directly into the imaging and measurement process represents a comprehensive approach to innovation in diagnostic ultrasound.

Support & Docs

LINQ II Insertable Cardiac Monitor

Medtronic, the company behind Tool B, is a well-established global leader with a vast customer base of over 1 million patients, implying a robust and extensive support infrastructure. The integrated MyCareLink Heartu2122 mobile app and MyCareLink Relayu2122 home communicator also provide direct patient-facing support and data transmission capabilities.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature cV5 Diagnostic Ultrasound System LINQ II Insertable Cardiac Monitor
Product Name cV5 Diagnostic Ultrasound System LINQ II Insertable Cardiac Monitor
Company Samsung Medison Co. Medtronic
Primary Specialties Cardiology, Obstetrics & Gynecology, Radiology Cardiology
Key AI Algorithms/Tools HeartAssistu2122, AutoEF, Strain+, TMAD, AutoIMT+, ArterialAnalysisu2122, BiometryAssistu2122 AccuRhythmu2122 AI algorithms, Innovative PVC detection algorithm
Data Export Capabilities AVI, MPEG, JPEG, TIFF, BMP, and DICOM formats yes
Mobile App Support Not specified MyCareLink Heartu2122 mobile app

Videos

Demos, reviews, and walkthroughs featuring cV5 Diagnostic Ultrasound System and LINQ II Insertable Cardiac Monitor.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

The Samsung cV5 Diagnostic Ultrasound System is a versatile, AI-assisted ultrasound solution offering high-quality imaging for confident decision-making across various medical specialties such as Cardiology, OB/GYN, and Radiology. In contrast, the Medtronic LINQ II Insertable Cardiac Monitor is an advanced, AI-powered insertable device providing long-term, continuous heart rhythm monitoring with enhanced accuracy for diagnosing arrhythmias, primarily in Cardiology.
The cV5 Diagnostic Ultrasound System incorporates AI and productivity tools like HeartAssistu2122, AutoEF, and BiometryAssistu2122 for enhanced image quality and streamlined workflows during diagnostic imaging. The LINQ II Insertable Cardiac Monitor, on the other hand, utilizes AccuRhythmu2122 AI algorithms and an innovative PVC detection algorithm to enhance accuracy in detecting and classifying cardiac arrhythmias for long-term monitoring.
The Samsung cV5 Diagnostic Ultrasound System is designed to support Cardiology, Obstetrics & Gynecology, and Radiology. The Medtronic LINQ II Insertable Cardiac Monitor is specifically indicated for use in Cardiology.
The cV5 Diagnostic Ultrasound System provides real-time diagnostic ultrasound images and measurements for immediate assessment. The LINQ II Insertable Cardiac Monitor offers long-term, continuous heart rhythm monitoring for up to 4.5 years, capturing and transmitting data on arrhythmias.
Yes, the Medtronic LINQ II Insertable Cardiac Monitor is MRI compatible (1.5 and 3.0T) and has a pediatric indication for patients aged 2 years and older. The Samsung cV5 Diagnostic Ultrasound System does not explicitly list these specific features in its description.
AI Tool Finder
AI-powered search. Results may not be comprehensive.